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A b s t r a c t  
Cefadroxil (CFD) is a broad spectrum antibiotic that acts against an extensive variety of bacteria, 
including Gram-positive and Gram-negative bacteria. The major drawback of orally administered 
drug like cefadroxil is its shorter half life of 1.2 hrs. The goal of the study is to prolong the drug 
release, producing a desired blood serum level, reduction in drug toxicity and improving the patient 
compliance by prolonging the dosing intervals. Cyclodextrin-based nanosponges (NS) are a novel 
class of cross-linked derivatives of cyclodextrins. They have been used to increase the solubility of 
poorly soluble actives, to protect the labile groups and control the release. This study aimed at 
formulating complexes of CFD with three types of β-cyclodextrin NS obtained with different cross-
linking ratio (viz. 1:2, 1:4 and 1:8 on molar basis with the cross-linker) to protect the lactone ring from 
hydrolysis and to prolong the release kinetics of CFD. Crystalline (F1:2, F1:4 and F1:8) and 
paracrystalline NS formulations were prepared. XRPD, DSC and FTIR studies confirmed the 
interactions of CFD with NS. XRPD showed that the crystallinity of CFD decreased after loading. 
CFD was loaded as much as 21%, 37% and 13% w/w in F1:2 , F1:4 and F1:8, respectively while the 
paracrystalline NS formulations gave a loading of about 10% w/w or lower. The particle sizes of the 
loaded NS formulations were between 450 and 600 nm with low polydispersity indices. The zeta 
potentials were sufficiently high (-20 to -25 mV) to obtain a stable colloidal nanosuspension. The in 
vitro studies indicated a slow and prolonged CFD release over a period of 24 h. The NS formulations 
protected the lactone ring of CFD after their incubation in physiological conditions at 37°C for 24 h 
with a 80% w/w of intact lactone ring when compared to only around 20% w/w of plain CFD. 
Keywords: Cefadroxil; cyclodextrins; nanosponges; paracrystalline. 
Introduction 
 
Cyclodextrins are naturally occurring cyclic oligosaccharides 
generally containing 6, 7 or 8 glucose units, respectively, known as 
α, β and γ cyclodextrins. They are characterized by a typical toroidal 
cone shape; the atom arrangement is such that the inside cavity is 
lipophilic, while the outside of the torus is highly hydrophilic. 
Cyclodextrins are thus able to form stable inclusion complexes with 
molecules of suitable polarity and size even in aqueous solutions. 
The complexation mechanism does not involve covalent bonds and 
the main driving force of complex formation is the release of 
enthalpy-rich water molecules from the cyclodextrin cavity [1]. 
Cyclodextrins (CDs) have found numerous applications in many 
fields due to their ability to complex with a wide range of compounds 
[2]. To improve the characteristics of native cyclodextrins, many 
derivatives have been prepared. Cyclodextrin conjugates with 
biocompatible hydrophilic polymers have been prepared to increase 
the solubility of β-CD and its complexes in aqueous media [3–6]. In 
polymeric conjugates, where a number of β-CD units are bound to 
the same polymer chain, it can happen that cooperation among 
several β-CD units increases the stability of the drug complex. 
Moreover, the polymer may cooperate with the β-CD moieties in 
stabilizing the complexes. 
It has recently been reported that, by reacting cyclodextrins with 
suitable crosslinking agents, a novel nanostructured material 
consisting of hyper-cross-liked cyclodextrins can be obtained; these 
are known as nanosponges [7–9]. This composite material shows 
interesting characteristics; in particular, cyclodextrin-based 
nanosponges are characterized by their marked capacity to 
encapsulate a great variety of substances that can be transported 
through aqueous media or, from the opposite perspective, removed 
from contaminated water. As a result, they could be a very efficient 
tool either to remove pollutants from water or to carry substances 
for biomedical applications. Thanks to their capacity to complex 
molecules, nanosponges have been proposed as drug delivery 
systems [10-11]. 
Cyclodextrin-based nanosponge aregenerally obtained by cross-
linking different types of cyclodextrins (CD) with a dicarboxylate or a 
carbonyl compound as cross-linker. These can be made from many 
ISSN: 0975-0215 
 
DOI:10.5138/09750215.2180 
  
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use  
and redistribution provided that the original author and source are credited. 
Dubey et al. International Journal of Drug Delivery 9 (3) 84-100 [2017] 
 
 
  
PAGE | 85 | 
 
 
different organic or inorganic materials; their structure presents a 
nanometric dimension or smaller. Well-known examples are 
titanium or other metal-oxide based nanosponges, silicon 
nanosponge particles, carbon coated metallic nanosponges, hyper-
cross-linked polystyrene nanosponges and also cyclodextrin based 
nanosponges. The common characteristic of these materials is the 
presence of nano-scale pores that give them particular properties 
[12]. In the pharmaceutical field, in particular, they could be 
employed as solubilizing agents or nanocarriers. 
 
Material and methods 
 
Materials 
 
Cefadroxil (CFD), Diphenyl carbonate, β-cyclodextrin were 
purchased from Sigma–Aldrich (Milan, Italy). All other chemicals 
and reagents were of analytical grade. Milli Q water (Millipore) was 
used throughout the studies. 
 
Synthesis of β-cyclodextrinnanosponges 
 
Nanosponges of β-cyclodextrin were prepared in series of three 
types using diphenylcarbonate for the cross-linking as described by 
Trotta, Cavalli et al. (2006). Concisely, diphenylcarbonate melted at 
90°C then anhydrous cyclodextrin added and placed for at least 5 h. 
Then, to remove the organic impurities after cool the mixture, it was 
ground in mortar and then sohxleted with ethanol for unreacted 
diphenyl carbonate. The reaction with a cross-linker excess was 
done with three different molar ratios: 1:2, 1:4, 1:8 (β-cyclodextrin: 
cross-linker). After purification, nanosponges were stored until 
further use at 25°C until further use. This reaction was also carried 
out in the presence of ultrasound, and two different types of NS, 
namely, crystalline (1:2 NS, 1:4 NS, 1:8 NS) and paracrystalline 
(1:2, 1:4, or 1:8 NSpara), were formed based on the process 
conditions of the synthesis. 
 
Preparation of Cefadroxil-loaded nanosponges 
 
CFD was dispersed in aqueous suspensions of the various types of 
nanosponges in a ratio of 1:4 (drug to NS by weight) and was stirred 
for 24 h in the dark and at acidic pH to avoid the formation of the 
carboxylate form of Cefadroxil. After 24 h, the suspensions were 
centrifuged at 2000 rpm for 10 min to separate the uncomplexed 
drug as a residue below the colloidal supernatant. The colloidal 
supernatants were freeze-dried to obtain drug-loaded NS 
formulations, named as F1:2, F1:4 and F1:8 and Fpara, depending 
upon the ratio of β-CD:cross-linker. The drug-loaded NS 
formulations were stored in a covered vacuum desiccator at room 
temperature until further use. 
 
Preparation of Cefadroxil physical mixtures 
Binary physical mixtures of the series of nanosponges with the drug 
were prepared by mixing appropriate amounts of solid components 
(4:1 NS:CFD weight ratio) in a glass mortar. 
 
Determination of CFD loading in nanosponges 
 
Weighed amount of loaded nanosponges were dispersed in a 
methanol:chloroform mixture (1:4 v/v), suitably diluted in methanol 
and were analyzed by HPLC. Briefly, a Shimadzu instrument model 
no. LC-9A, equipped with C R5A cromatopac integrator and RF-551 
spectrofluorometric detector in isocratic conditions was used. The 
separation was carried out using an octadecylsilane column with a 5 
µm pore size with a mobile phase containing acetonitrile and 
triethanolamine aqueous solution (1% w/v) in a ratio of 35:65 (v:v) 
using a fluorescent detector at a λex = 360 nm and λex = 440 nm. 
The flow rate was kept at 0.8 ml/min. The peak of CFD (lactone) 
was obtained at a retention time of about 9 min and that of 
carboxylate form (if present) was obtained at a retention time of 
about 3 min. The standard solutions of CFD -lactone and CFD -
carboxylate for the calibration curves were made by dilution of the 
CFD stock solution in dimethylsulfoxide. The analysis of the 
carboxylate form was carried out 24 h after preparing the solution in 
NaOH 0.1 N to ensure the complete conversion of the CFD-lactone 
to the carboxylate forms. The calibration curves were linear in the 
range 0.1–0.5 ug/ml. 
 
Physicochemical characterization of CFD-loaded 
nanosponges 
 
Fourier Transform Infrared spectroscopy (FTIR) 
 
It was performed, using a Perkin Elmer system 2000 
spectrophotometer, to understand if there exists some interaction 
between drug and NS. To prepare the pellets, a few milligrams of 
the sample were ground together in a mortar with about 100 times 
the quantity of potassium bromide (KBr). The finely ground powder 
was introduced into a stainless steel die. The powder was then 
pressed in the die between polished stainless steel anvils at a 
pressure of about 10000 psi. The spectra were obtained on KBr 
pellets in the region from 4000 cm-1 to 500 cm-1. 
 
Differential scanning calorimetry (DSC) 
 
It was carried out by means of a Perkin Elmer DSC/7 differential 
scanning calorimeter (Perkin-Elmer, CT-USA) equipped with a TAC 
7/DX instrument controller. The instrument was calibrated with 
indium for melting point and heat of fusion. A heating rate of 
10°C/min was employed in the 25–300°C temperature range. 
Standard aluminum sample pans (Perkin-Elmer) were used; an 
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empty pan was used as reference standard. Analyses were 
performed in triplicate on 5 mg samples under nitrogen purge. 
 
Size, polydispersity index and zeta potential values  
 
NS sizes and polydispersity indices were measured by dynamic 
light scattering using a 90 Plus particle sizer (Brookhaven 
Instruments Corporation, USA) equipped with MAS OPTION particle 
sizing software. The measurements were made at a fixed angle of 
90° for all samples and 25°C. The samples were suitably diluted with 
filtered distilled water for every measurement. Zeta potential 
measurements were also made using an additional electrode in the 
same instrument. For zeta potential determination, samples of the 
three formulations were diluted with 0.1 mMKCl and placed in the 
electrophoretic cell, where an electric field of about 15 V/cm was 
applied. 
 
Optical microscopy (OM)  
 
The NS suspensions were observed using a Leitz invert microscope 
after suitable dilution with water and saline solution to evaluate the 
effect of the dilution on the NS formulations. The OM was also used 
to investigate the morphology of erythrocytes after the incubation 
with the NS. 
 
Scanning electron microscopy (SEM)  
 
It was employed to evaluate the structure and surface morphology 
of the nanosponge A Philips CM 10 Scanning electron microscope 
was used, and the particle size was measured using the NIH image 
software. The nanosponge suspensions were sprayed on Formwar-
coated copper grid and air-dried before observation. 
 
Fourier transform infrared (FTIR) spectra of different 
nanosponges 
 
The FTIR spectra of 1:2 , 1:4 , 1:8 nanosponges was done in order 
to confirm the presence of the carbonate bond in the nanosponges . 
This shows the occurrence of crosslinking between the 
cyclodextrin.which has a peak at around 1700––1750 cm-1. 
 
In-vivo studies  
 
In-vivo studies were performed on 2 group of albino rats weighing 
250 grams. Dose for albino rat were calculated by using ‘Oncology 
tool: Dose calculator’ [27]. Target dose of 7.69 mg/kg/12 hrs of 
cefadroxil was given to rat. Oral suspension of cefadroxil and 
cefadroxilnanosponges suspended in saline solution to achieve 
concentration of 1 mg/ ml of cefadroxil was prepared and is 
administered by orogastric gavage after anaesthesia. Animal is 
divided into 2 groups, one rat in Control group and four rat in 
complex group. Sample were analysed by UV spectroscopy and 
analysis was done for data studies and pharmacokinetic analysis. 
 
Statistical analysis 
  
Statistical analysis of differences among the formulations was 
performed using Student’s t-test. A 0.05 level of probability was 
taken as level of significance. 
 
Results and discussion 
 
Cefadroxil was odorless, off white to yellowish, crystalline powder. 
The physical properties matched with the IP specifications. 
Identification of drug was confirmed by melting point study, UV 
spectra and FTIR spectra. Melting point found after triplicate study 
was 197.33˚C±0.471 and this complies with the pharmacopoeial 
specification so it was confirmed that sample obtained was 
cefadroxil (I.P 1996) 
 
FTIR Spectroscopy  
 
The FTIR of sample cefadroxil was taken (fig 1 ). On interpretation 
of FTIR spectra of drug it showed characteristic absorbance band at 
1354 cm-1 and 1759 cm-1 of Cefadroxil which were due to stretching 
vibration of C-N (beta lactam)and C=O (beta lactam) bond 
respectively. All other indication showed that the drug sample was 
authentic and pure. 
 
 
 
 
 
Figure 1: 
 
Determination of partition coefficient 
 
The partition coefficient (Po/w) was found to be 0.398 using octanol
buffer systems. The Log P value -0.41 indicating hydrophilic nature 
of the drug and which does not cross biological membrane very 
easily. 
 
Figure 2: Absorption maximum of cefadroxil in phosphate buffer (pH 7.4)
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Determination of Absorption maxima (
 
The absorption maxima of cefadroxil was determined in phosphate 
buffer (7.4) (figure 2) in methanol (fig
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Figure 3: Absorption maxima (λmax) of cefadroxil in methanol 
 
 
Compatibility studies FTIR spectra of cyclodextrin 
 
Drug polymer interaction study is very important to check the 
compatibility of drug and polymers.study implies that the stability of 
drug in presence of excipients.it is done with spectroscopy by Kbr 
pellet technique using FTIR spectrophotometer (Shumadzu FTIR-
8400S). the combination for this are: Drug –cefadroxil 
Cyclodextrin 
Diphenylcarbonate 
Cyclodextrin + cefadroxil 
Cyclodextrin + diphenylcarbonate 
Cyclodextrin + diphenylcarbonate + cefadroxil 
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Figure 4: FTIR spectra of cyclodextrin. 
 
Figure 5 : FTIR spectra of diphenylcarbonate. 
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Figure 6: FTIR spectra of cyclodextrin and dpc 
 
Figure 7: FTIR spectra of cefadroxil  andcyclodextrin 
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Figure 8: FTIR spectra of cefadroxil  anddpc 
 
Figure 9: FTIR spectra of cefadroxil and dpc and cyclodextrin 
 
The FTIR study was done for compatibility study with the cefadroxil. 
FTIR spectra of drug showed charctersitic absorbance band at 1354 
cm -1 and 1759 cm -1 of cefadroxil which were due to stretching 
vibration of C-N (beta lactam) and C=O (beta lactam) bond 
respectively. The cyclodextrin is characterized by absorbance band 
at 3300-3600 cm-1 for OH group, 1000-1260 cm-1 for –CO group 
and 2800-3300 cm-1 for –CH, -CH2 group. The diphenylcarbonatye 
is characterized by the absorbance band at 1753 cm-1 for 
carbonate bond. There was no shifting of peaks seen in the IR 
spectra of cefadroxil with diphenyl carbonate (fig 8). So it was 
concluded that there was no interaction with the diphenyl carbonate. 
With cyclodeextrin there is characteristic changes seen in the drug 
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region which can be attributed to the loss of crystallinity of the drug. 
A similar changes was seen with FTIR of the cefadroxil, 
cyclodextrin, diphenyl carbonate mixture. 
 
Scanning Electron Microscopy  
 
Scanning electron microscopy of Nanosponges was done to reveal 
the structure and surface morphology of the nanosponge. Scanning 
Electron Microscopy of ¼ nanosponges illustrated irregular shaped 
rough surface and porous of the nanosponges. The surface 
morphology shows a porous structure of nanosponges. 
 
(A) 
 
(B) 
Figure 10:  (A) SEM of  nanosponge (B) SEM indicating Surface morphology of nanosponge. 
 
 
 
Fourier transform infrared (FTIR) spectra of different 
nanosponges 
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The FTIR spectra of  1:2 , 1:4 , 1:8 
to confirm the presence of the carbonate bond in the nanosponges . 
This shows the occurrence of crosslinking between the 
cyclodextrin.which has a peak at around 1700
 
Figure 11 : FTIR spectra of 1:2 nanosponges 
Figure 12: FTIR spectra of 1:4 nanosponges 
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Figure 13: FTIR spectra of 1:8 nanosponges 
 
The FTIR spectra of nanospongesviz 1:2 (fig 11), 1:4 (fig 12), 1:8(fig 
13) nanosponges showed the presence of the carbonate bond 
which has a peak around 1700-1750 cm-1 .The presence of 
carbonate bond sowed that the crosslinking was occurred between 
the cyclodextrin. 
 
FTIR of drug loaded nanosponges 
 
The FTIR of drug loaded nanosponges was done to determine any 
changes in the physical form of drug in the nanosponges. 
 
Figure 14: FTIR spectra of drug loaded 1:2 nanosponges 
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Figure 15: FTIR spectra of drug loaded 1:4 nanosponges 
 
Figure 16: FTIR spectra of drug loaded 1:8 nanosponges 
 
FTIR spectra of drug loaded nanosponges shows broadening of 
peak in the drug region of 1500 cm-1 to 1700 cm-1 which shows 
there is significant changes in the drug which may be associated 
with the loss of crystallinity. 
 
Differential Scanning Calorimetery studies 
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Figure 17: Differential scanning calorimetry of cefadroxil 
 
Figure 18: DSC of ¼ Nanosponge 
 
 
 
 
Figure 19: 
 
The DSC thermograms for drug (cefadroxil) (fig 17) and ¼ 
nanosponge (fig 18) are shown . The DSC thermogram of cefadroxil 
shows a less intense endothermic peak at 223 °C corresponding to 
its melting point. The onset of melting was observed at 214 °C. The 
DSC thermogram of β-CD nanosponges showed a broad peak at 
274 °C .The DSC thermogram of cefadroxil with β-
(fig 19) showed a broad peak at 170 °C for the cefadroxil and 
another peak at 274 °C for β-CD nanosponges, indicating drug 
amorphization. 
 
Figure 20 : 
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DSC of cefadroxil loaded ¼ Nanosponge 
CD nanosponges 
 
In vivo Studies 
  
Standard curve of cefadroxil in blood serum
 
The standard curve of cefadroxil in blood serum was scanned at 
232.4 nm. 
Standard curve of drug in blood serum 
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Figure 21: Regression coefficient of cefadroxil in blood serum 
 
Table 1:  Time and plasma concentration data of cefadroxil of plain and drug loaded nanosponges 
Time  
(minutes) 
Concentration (µg/ml) 
(Control group) 
Concentration (µg/ml) 
(Complex group) 
5 0 0 
10 4.7 15.4±0.8 
15 6.2 18.1±0.026 
30 10.8 23±0.4 
60 12.3 26.6±1.2 
120 12.1 25.3±0.3 
 
 
Figure 22: Plot of the plasma time concentration of cefadroxil 
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The peak plasma concentration of cefadroxil was found to be 12.3 
µg/ml after one hour while that for the nanosponges the peak 
plasma concentration was found to be 26.6 µg/ml after one hour. 
These study shows that there is an increase in the absorption of the 
drug. 
 
Summary and Conclusion 
 
In the present study we have selected drug cefadroxil due to poor 
solubility. It has many side effect such as nausea, vomiting, gastric 
irritation, darkening of tongue. It has broad spectrum activity against 
Gm-ve, Gm+ve, aerobic and anaerobic bacteria. Nanosponges as a 
delivery system has a good capacity to entrap high percentage of 
drug as well as improved dissolution kinetics. We have prepared 
three molar ratio of nanosponges by crosslinking β-cyclodextrin with 
the Diphenyl carbonate. The nanosponge were prepared by 
ultrasound assisted synthesis and drug loading was done to form 
solid dispersion. The entrapment efficiency of the N2 is highest 
(70.57 %). The phase solubility studies shows formulation N2 shows 
highest solubility of drug in water. The DSC studies shows the 
shifting of melting peaks from 216 °C to 170 °C which shows 
amorphization of drug. The in vivo studies of formulation N2 shows 
that there is an increase in the absorption of the drug with respect to 
the pure drug. The FTIR spectra for compatibility study with the 
cefadroxil shows no significant changes in the drug with 
diphenylcarbonate. With cyclodextrin there is characteristic changes 
in the drug region which can be attributed to the loss of crystallinity 
of the drug. A similar changes was seen in the FTIR of the 
cefadroxil ,cyclodextrin, diphenylcarbonate mixture. Nanosponges 
as a delivery system has a good capacity to entrap high percentage 
of drug as well as improved dissolution kinetics. It can also be 
administer in the form of solution. Plane nanosponges had particle 
size approx. 250-310 µm. SEM study shows that the particle are 
irregular in shape. The surface of the nanosponges is rough and 
highly porous in nature. On FTIR spectra of different 
nanospongesviz 1:2, 1:4, 1:8 nanosponges showed the presence of 
the carbonate bond which has a peak at around 1750 cm-1. The 
FTIR spectra of drug nanosponge shows no inferring peaks which 
suggest no interaction between drug and nanosponges. 
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